Found: 19
Select item for more details and to access through your institution.
Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.
- Published in:
- Rheumatology, 2009, v. 48, n. 5, p. 513
- By:
- Publication type:
- Article
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02646-0
- By:
- Publication type:
- Article
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 7, p. 3088, doi. 10.1007/s12325-022-02160-y
- By:
- Publication type:
- Article
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 1, p. 121, doi. 10.1002/art.41466
- By:
- Publication type:
- Article
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial.
- Published in:
- Annals of Internal Medicine, 2005, v. 142, n. 12, p. 953, doi. 10.7326/0003-4819-142-12_Part_1-200506210-00004
- By:
- Publication type:
- Article
Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1871, doi. 10.1007/s40744-021-00351-7
- By:
- Publication type:
- Article
Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 3, p. 1189, doi. 10.1007/s40744-021-00328-6
- By:
- Publication type:
- Article
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 1, p. 573, doi. 10.1007/s40744-021-00294-z
- By:
- Publication type:
- Article
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Rheumatology & Therapy, 2020, v. 7, n. 4, p. 893, doi. 10.1007/s40744-020-00236-1
- By:
- Publication type:
- Article
SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1327437
- By:
- Publication type:
- Article
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus.
- Published in:
- Lupus, 2021, v. 30, n. 8, p. 1254, doi. 10.1177/09612033211014267
- By:
- Publication type:
- Article
The Spectrum of Health Domains Important to Lupus Patients: Early Development of a Disease Activity Patient Reported Outcome.
- Published in:
- Bulletin of the Hospital for Joint Diseases, 2019, v. 77, n. 2, p. 92
- By:
- Publication type:
- Article
SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.654839
- By:
- Publication type:
- Article
Role of Platelet‐Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 10, p. 2088, doi. 10.1002/acr.25107
- By:
- Publication type:
- Article
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 7, p. 1399, doi. 10.1002/acr.25007
- By:
- Publication type:
- Article
Comparison of the Lupus Foundation of America-Rapid Evaluation of Activity in Lupus to More Complex Disease Activity Instruments As Evaluated by Clinical Investigators or Real-World Clinicians.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Belimumab in systemic lupus erythematosus: a perspective review.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2015, v. 7, n. 4, p. 115, doi. 10.1177/1759720X15588514
- By:
- Publication type:
- Article